|
MechanismMat2A inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismMat2A inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismPRMT5 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Suzhou Youli Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Suzhou Youli Biomedical Technology Co., Ltd.
100 Deals associated with Suzhou Youli Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Suzhou Youli Biomedical Technology Co., Ltd.